The final, formatted version of the article will be published soon.
ORIGINAL RESEARCH article
Front. Stroke
Sec. Preventative Health and Stroke Complications
Volume 3 - 2024 |
doi: 10.3389/fstro.2024.1496003
This article is part of the Research Topic Mobile Health for Assisting Stroke Survivors View all articles
PHOTOPLETHYSMOGRAPHY-BASED ATRIAL FIBRILLATION DETECTION IN PATIENTS AFTER CRYTPOGENIC STROKE
Provisionally accepted- Amsterdam UMC, Amsterdam, Netherlands
Introduction Undiagnosed atrial fibrillation (AF) is a potential underlying cause of cryptogenic stroke. Prolonged screening for AF using a photoplethysmography (PPG) smartwatch might offer a solution for detecting AF in patients with cryptogenic stroke. In this study, we aim to investigate this strategy by comparing AF detection rates using a PPG-smartwatch and 48h Holter monitor. Methods From December 2019, patients with cryptogenic stroke were included to undergo 28 days of semi-continuous AF monitoring using a Fitbit smartwatch with a PPG-based FibriCheck algorithm, with simultaneous Holter monitoring during the first 48 hours. From April 2021, a detailed screening log was installed to characterize potential study participants. Results After logged screening of 1312 patients, enrollment was prematurely halted due to slower-than-expected inclusion rates. 40.8% of the screened patients had cryptogenic stroke, of which 92.5% were non-eligible for inclusion due to logistical, technological, and study-related challenges. Of the 43 patients enrolled, 37 completed PPG monitoring using a smartwatch. 43% of patients had PPG-detected AF in the 28 days after cryptogenic stroke. During the first 48 hours, PPG-based screening detected AF in 2 patients, whereas no AF was detected using concurrent Holter monitoring. Conclusion The PPG-smartwatch detected AF in 43% of the participants after cryptogenic stroke. However, discrepancies with concurrent Holter monitoring raise major concerns about the accuracy of the detected PPG-based AF. Moreover, the feasibility of a PPG-based screening strategy is limited due to logistical and technological challenges, partly inherent to cryptogenic stroke patients.
Keywords: cryptogenic stroke, Atrial Fibrillation, Photoplethysmography (PPG), Holter monitoring, Screening for AF
Received: 13 Sep 2024; Accepted: 14 Nov 2024.
Copyright: © 2024 Huntelaar, Selder, Hopman, Visser and Allaart. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence:
Marthe J. Huntelaar, Amsterdam UMC, Amsterdam, Netherlands
Jasper L. Selder, Amsterdam UMC, Amsterdam, Netherlands
Marieke C. Visser, Amsterdam UMC, Amsterdam, Netherlands
Cornelis P. Allaart, Amsterdam UMC, Amsterdam, Netherlands
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.